IDiyas

For the Inventor, By the Inventor

Hino, Japan

Takeshi Toru

USPTO Granted Patents = 10

Average Co-Inventor Count = 6.6

ph-index = 5

Forward Citations = 48(Granted Patents)


Location History:

  • Hino, JA (1977)
  • Hino, JP (1979)
  • Hachioji, JP (1983 - 1984)

Company Filing History:

goldMedal10 out of 1,586 
 
Teijin Limited
 patents

Years Active: 1977-1984

Loading Chart...
10 patents (USPTO):Explore Patents
1. 4472428 - Halogenated prostacyclins pharmaceutical use thereof and hydroxy (1984-09-18),
2. 4466980 - Thiaprostaglandin E.sub.1 derivatives, process for production thereof, (1984-08-21),
3. 4421914 - Thiazolo[3,2-a]pyrimidines, derivatives thereof, processes for (1983-12-20),
4. 4180672 - 2-Organothio-2-cyclopentenones, organothio-cyclopentanes derived (1979-12-25),
5. 4139717 - 1,3-Dicarbonyl compounds (1979-02-13),
6. 4132726 - Process for the preparation of 4-hydroxycyclopent-2-en-1-one derivatives (1979-01-02),
7. 4039563 - Process for preparing cyclopent-2-en-1-one derivatives (1977-08-02),
8. 4009196 - 2-Acyl-3-substituted cyclopentan-1-ones and process for their preparation (1977-02-22),
9. 4008125 - New cyclopentene-diols and new acyl esters thereof and process for their (1977-02-15),
10. 4001308 - Process for the preparation of 1,4-diacetoxycyclopent-2-ene (1977-01-04),

Title: Innovations of Takeshi Toru

Introduction

Takeshi Toru is a prominent inventor based in Hino, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds with therapeutic applications. With a total of 10 patents to his name, his work has had a substantial impact on medical science.

Latest Patents

Takeshi's latest patents include groundbreaking inventions such as halogenated prostacyclins and thiaprostaglandin E1 derivatives. The halogenated prostacyclins are particularly noteworthy for their pharmaceutical use in controlling vascular actions and their applications in organ transplantation and extra-corporeal circulation. His work on thiaprostaglandin E1 derivatives involves novel compounds that can be synthesized through various chemical reactions, showcasing his innovative approach to drug development.

Career Highlights

Throughout his career, Takeshi has been associated with Teijin Limited, where he has collaborated with other talented researchers. His dedication to advancing pharmaceutical science is evident in his extensive research and patent filings. His inventions are not only innovative but also address critical medical needs.

Collaborations

Takeshi has worked alongside esteemed colleagues such as Seizi Kurozumi and Toshio Tanaka. Their collaborative efforts have led to significant advancements in the field, further enhancing the impact of their research.

Conclusion

Takeshi Toru's contributions to pharmaceutical innovations exemplify the importance of research and development in improving healthcare. His patents reflect a commitment to addressing complex medical challenges through innovative solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…